Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Exposure Prophylaxis | 20 | 2025 | 196 | 9.870 |
Why?
|
| Anti-HIV Agents | 16 | 2025 | 1324 | 4.690 |
Why?
|
| HIV Infections | 26 | 2025 | 5097 | 4.110 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2024 | 103 | 2.890 |
Why?
|
| Reproductive Health Services | 4 | 2024 | 66 | 2.260 |
Why?
|
| Adolescent | 20 | 2025 | 2985 | 1.950 |
Why?
|
| South Africa | 19 | 2025 | 7596 | 1.370 |
Why?
|
| Humans | 30 | 2025 | 14537 | 1.330 |
Why?
|
| Female | 23 | 2025 | 9103 | 1.320 |
Why?
|
| Sex Workers | 2 | 2023 | 116 | 1.290 |
Why?
|
| Young Adult | 11 | 2025 | 2498 | 1.170 |
Why?
|
| Primary Health Care | 3 | 2025 | 240 | 1.120 |
Why?
|
| Male | 13 | 2025 | 6754 | 1.090 |
Why?
|
| Heterosexuality | 2 | 2024 | 30 | 1.030 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2025 | 256 | 0.980 |
Why?
|
| Qualitative Research | 2 | 2025 | 321 | 0.910 |
Why?
|
| Homosexuality, Male | 3 | 2023 | 52 | 0.870 |
Why?
|
| Choice Behavior | 1 | 2024 | 16 | 0.860 |
Why?
|
| Patient Preference | 1 | 2024 | 30 | 0.850 |
Why?
|
| Administration, Oral | 5 | 2025 | 127 | 0.830 |
Why?
|
| Safety | 1 | 2024 | 34 | 0.820 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 262 | 0.800 |
Why?
|
| Schools | 1 | 2024 | 73 | 0.790 |
Why?
|
| Violence | 1 | 2024 | 68 | 0.790 |
Why?
|
| Adult | 11 | 2025 | 5913 | 0.780 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2023 | 187 | 0.770 |
Why?
|
| Contraception | 2 | 2023 | 90 | 0.750 |
Why?
|
| Fertilization | 2 | 2019 | 22 | 0.730 |
Why?
|
| Interviews as Topic | 4 | 2025 | 203 | 0.700 |
Why?
|
| Withholding Treatment | 1 | 2020 | 26 | 0.630 |
Why?
|
| Patient Selection | 1 | 2019 | 40 | 0.590 |
Why?
|
| Safe Sex | 1 | 2019 | 68 | 0.580 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 1422 | 0.580 |
Why?
|
| Decision Making | 1 | 2019 | 53 | 0.580 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 112 | 0.570 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 563 | 0.500 |
Why?
|
| Middle Aged | 4 | 2025 | 3601 | 0.490 |
Why?
|
| HIV | 3 | 2023 | 380 | 0.460 |
Why?
|
| Sexual Behavior | 3 | 2023 | 320 | 0.440 |
Why?
|
| Anti-Retroviral Agents | 1 | 2019 | 551 | 0.440 |
Why?
|
| Contraceptive Devices, Female | 2 | 2023 | 30 | 0.370 |
Why?
|
| Health Services Accessibility | 2 | 2025 | 280 | 0.360 |
Why?
|
| Family Planning Services | 1 | 2009 | 46 | 0.300 |
Why?
|
| Pregnancy | 4 | 2023 | 1862 | 0.280 |
Why?
|
| Syphilis, Congenital | 2 | 2004 | 13 | 0.260 |
Why?
|
| Risk Factors | 2 | 2020 | 1475 | 0.230 |
Why?
|
| Seroconversion | 1 | 2025 | 5 | 0.220 |
Why?
|
| HIV Seropositivity | 2 | 2025 | 265 | 0.220 |
Why?
|
| Africa South of the Sahara | 3 | 2021 | 353 | 0.210 |
Why?
|
| Counseling | 2 | 2019 | 143 | 0.210 |
Why?
|
| Zimbabwe | 2 | 2021 | 120 | 0.200 |
Why?
|
| Injections | 1 | 2024 | 31 | 0.200 |
Why?
|
| Motivation | 1 | 2024 | 59 | 0.200 |
Why?
|
| Reproductive Health | 1 | 2023 | 51 | 0.200 |
Why?
|
| Mental Health | 1 | 2023 | 91 | 0.190 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2004 | 529 | 0.180 |
Why?
|
| Cohort Studies | 1 | 2025 | 967 | 0.180 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 57 | 0.180 |
Why?
|
| Mass Screening | 2 | 2019 | 245 | 0.170 |
Why?
|
| Condoms | 1 | 2020 | 88 | 0.150 |
Why?
|
| Women's Health | 1 | 2019 | 41 | 0.140 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 39 | 0.140 |
Why?
|
| Sexual Partners | 1 | 2019 | 215 | 0.140 |
Why?
|
| Medication Adherence | 1 | 2018 | 151 | 0.130 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 115 | 0.130 |
Why?
|
| Retrospective Studies | 1 | 2019 | 799 | 0.120 |
Why?
|
| Chemoprevention | 1 | 2016 | 33 | 0.120 |
Why?
|
| Disease Transmission, Infectious | 1 | 2016 | 39 | 0.120 |
Why?
|
| Kenya | 2 | 2021 | 183 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2009 | 101 | 0.070 |
Why?
|
| Syphilis Serodiagnosis | 2 | 2004 | 7 | 0.060 |
Why?
|
| Prenatal Care | 2 | 2004 | 147 | 0.060 |
Why?
|
| Program Development | 1 | 2004 | 32 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2022 | 35 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2002 | 30 | 0.040 |
Why?
|
| Syphilis | 1 | 2002 | 14 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2021 | 32 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2004 | 472 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 106 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2004 | 1479 | 0.040 |
Why?
|
| Health Personnel | 1 | 2021 | 231 | 0.040 |
Why?
|
| Colposcopy | 1 | 2019 | 17 | 0.040 |
Why?
|
| Papanicolaou Test | 1 | 2019 | 29 | 0.040 |
Why?
|
| Infant | 1 | 2004 | 2244 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 179 | 0.030 |
Why?
|
| Maternal-Child Health Centers | 1 | 2002 | 3 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 507 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 480 | 0.010 |
Why?
|
| Child | 1 | 2002 | 2242 | 0.010 |
Why?
|